0001493152-21-020490.txt : 20210817
0001493152-21-020490.hdr.sgml : 20210817
20210817215611
ACCESSION NUMBER: 0001493152-21-020490
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200813
FILED AS OF DATE: 20210817
DATE AS OF CHANGE: 20210817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Drexler Ryan Charles
CENTRAL INDEX KEY: 0001648033
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53166
FILM NUMBER: 211184917
MAIL ADDRESS:
STREET 1: 525 CHALETTE DRIVE
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MusclePharm Corp
CENTRAL INDEX KEY: 0001415684
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770664193
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4721 IRONTON STREET
CITY: DENVER
STATE: CO
ZIP: 80239
BUSINESS PHONE: (800) 210-7369
MAIL ADDRESS:
STREET 1: 4721 IRONTON STREET
CITY: DENVER
STATE: CO
ZIP: 80239
FORMER COMPANY:
FORMER CONFORMED NAME: Tone in Twenty
DATE OF NAME CHANGE: 20071018
4
1
ownership.xml
X0306
4
2020-08-13
0
0001415684
MusclePharm Corp
MSLP
0001648033
Drexler Ryan Charles
C/O MUSCLEPHARM CORPORATION
3753 HOWARD HUGHES PARKWAY SUITE-200-849
LAS VEGAS
NV
89169
1
1
1
0
CEO
Convertible Promissory Note
2021-08-13
4
J
0
2457549
A
2022-07-14
Common Stock
2457549
D
On October 15, 2020, Mr. Drexler entered into a convertible secured promissory note agreement with a principal amount of $2,457,549 with the Company. (the "October 2020 Convertible Note"). Both the principal and any accrued but unpaid interest under the October 2020 Convertible Note will become due and payable on July 14, 2022, unless earlier converted or repaid.
Closing price on October 15, 2021
Determined on October 15, 2021
/s/ Ryan Charles Drexler
2021-08-17